Strata Critical Medical, Inc. - Class A Stock (SRTA)
CUSIP: 092667104
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Class A Stock
- Shares outstanding
- 85,979,314
- Total 13F shares
- 47,286,362
- Share change
- +2,683,062
- Total reported value
- $239,206,127
- Put/Call ratio
- 123%
- Price per share
- $5.06
- Number of holders
- 136
- Value change
- +$14,930,619
- Number of buys
- 66
- Number of sells
- 61
Quarterly Holders Quick Answers
What is CUSIP 092667104?
CUSIP 092667104 identifies SRTA - Strata Critical Medical, Inc. - Class A Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 092667104:
Top shareholders of SRTA - Strata Critical Medical, Inc. - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
13D/G
|
Company |
7.5%
from 13D/G
|
8,599,634
|
$34,656,525 | — | 30 Jun 2025 | |
| Third Point LLC |
13D/G
|
— |
5.8%
|
5,000,000
|
$25,300,000 | $0 | 30 Sep 2025 | |
| Robert S. Wiesenthal |
3/4/5
|
Director |
6.1%
|
5,275,662
|
$23,371,182 | — | 29 Aug 2025 | |
| BlackRock, Inc. |
13F
|
Company |
—
mixed-class rows
|
4,280,126
mixed-class rows
|
$17,248,717 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
3,299,015
|
$13,295,030 | — | 30 Jun 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
3.5%
|
2,999,192
|
$12,086,744 | — | 30 Jun 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
3.5%
|
2,999,192
|
$12,086,744 | — | 30 Jun 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
3.2%
|
2,765,468
|
$11,144,836 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.2%
|
1,921,783
|
$7,745,250 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
1,552,933
|
$6,259,706 | — | 30 Jun 2025 | |
| Uniplan Investment Counsel, Inc. |
13F
|
Company |
1.6%
|
1,362,766
|
$5,491,949 | — | 30 Jun 2025 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
1.6%
|
1,353,620
|
$5,455,089 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
1,293,656
|
$5,213,434 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
932,406
|
$3,757,596 | — | 30 Jun 2025 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
891,470
|
$3,592,624 | — | 30 Jun 2025 | |
| CANNELL CAPITAL LLC |
13F
|
Company |
1%
|
862,844
|
$3,477,261 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.83%
|
711,686
|
$2,868,095 | — | 30 Jun 2025 | |
| Eric Affeldt |
3/4/5
|
Director |
0.68%
|
581,214
|
$2,353,916 | — | 01 Aug 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.66%
|
566,086
|
$2,281,330 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
483,183
|
$1,947,227 | — | 30 Jun 2025 | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd |
13F
|
Company |
0.51%
|
439,256
|
$1,770,202 | — | 30 Jun 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.42%
|
358,105
|
$1,443,163 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.35%
|
298,624
|
$1,203,455 | — | 30 Jun 2025 | |
| Tidal Investments LLC |
13F
|
Company |
0.34%
|
293,065
|
$1,181,052 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.34%
|
289,413
|
$1,166,334 | — | 30 Jun 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
280,000
|
$1,128,400 | — | 30 Jun 2025 | |
| DnB Asset Management AS |
13F
|
Company |
0.31%
|
267,568
|
$1,078,299 | — | 30 Jun 2025 | |
| Bouvel Investment Partners, LLC |
13F
|
Company |
0.3%
|
255,470
|
$1,029,544 | — | 30 Jun 2025 | |
| Seth J. Bacon |
3/4/5
|
CEO, Trinity Air Medical |
—
class O/S missing
|
340,785
|
$1,001,908 | — | 13 Jun 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0.28%
|
244,282
|
$984,456 | — | 30 Jun 2025 | |
| Edward M. Philip |
3/4/5
|
Director |
0.27%
|
234,165
|
$948,368 | — | 01 Aug 2025 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.26%
|
227,427
|
$916,531 | — | 30 Jun 2025 | |
| John Borthwick |
3/4/5
|
Director |
0.24%
|
203,977
|
$826,106 | — | 01 Aug 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.23%
|
199,458
|
$803,816 | — | 30 Jun 2025 | |
| Kenneth B. Lerer |
3/4/5
|
Director |
0.23%
|
196,859
|
$797,278 | — | 01 Aug 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
197,654
|
$796,545 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.23%
|
196,000
|
$789,880 | — | 30 Jun 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.22%
|
189,111
|
$762,117 | — | 30 Jun 2025 | |
| Susan M. Lyne |
3/4/5
|
Director |
0.22%
|
187,185
|
$758,099 | — | 01 Aug 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.22%
|
187,890
|
$757,197 | — | 30 Jun 2025 | |
| Boston Partners |
13F
|
Company |
0.21%
|
184,709
|
$744,380 | — | 30 Jun 2025 | |
| Intellectus Partners, LLC |
13F
|
Company |
0.21%
|
176,550
|
$711,496 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
—
mixed-class rows
|
177,241
mixed-class rows
|
$709,315 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.19%
|
161,591
|
$651,212 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
146,696
|
$591,187 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.17%
|
145,992
|
$588,347 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.17%
|
144,167
|
$580,994 | — | 30 Jun 2025 | |
| David Zaslav |
3/4/5
|
Director |
—
class O/S missing
|
3,127,284
|
$562,911 | — | 22 Sep 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.16%
|
134,719
|
$542,908 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.15%
|
129,394
|
$521,458 | — | 30 Jun 2025 |
Institutional Holders of Strata Critical Medical, Inc. - Class A Stock (SRTA) as of Q3 2025
As of 30 Sep 2025,
Strata Critical Medical, Inc. - Class A Stock (SRTA) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,286,362 shares.
The largest 10 holders included
ARK Investment Management LLC, Third Point LLC, BlackRock, Inc., VANGUARD GROUP INC, AWM Investment Company, Inc., Sumitomo Mitsui Trust Group, Inc., Amova Asset Management Americas, Inc., DIMENSIONAL FUND ADVISORS LP, First Eagle Investment Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
136
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
124
Q3 2025 holders
136
Holder diff
12
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.